| Number of panellists (%) (n = 30) |
---|---|
Workplace location | |
 Scotland | 2 (7%) |
 Northern Ireland | 4 (13%) |
 Wales | 2 (7%) |
 North West | 5 (17%) |
 Yorkshire and the Humber | 9 (30%) |
 South West | 3 (10%) |
 South East | 1 (3%) |
 London | 4 (13%) |
Current professional rolea | |
 Orthopaedic surgeon | 5 (17%) |
 Advanced arthroplasty practitioner | 2 (7%) |
 Nurse | 2 (7%) |
 Physiotherapist | 12 (40%) |
 Occupational therapist | 4 (13%) |
 Rehabilitation assistant | 3 (10%) |
 Psychotherapist | 1 (3%) |
 Clinical commissioner | 3 (10%) |
 Manager | 2 (7%) |
 Researcher | 2 (7%) |
Years’ experience as a health professional | |
 0–9 | 5 (17%) |
 10–19 | 11 (37%) |
 20–29 | 9 (30%) |
 30–49 | 5 (17%) |
Workplace settinga | |
 NHS teaching hospital | 18 (60%) |
 NHS district/general hospital | 7 (23%) |
 Private Hospital or other private location(s) | 5 (17%) |
 Commissioning organisation | 3 (10%) |
 Increasing Access to Psychological Therapies | 1 (3%) |
Currently provide clinical care to patients who are listed for or have undergone TKR surgery | |
 Yes | 27 (90%) |
 No | 3 (10%) |
Phases of the TKR pathway currently work in (n = 27)a,b | |
 Pre-operative phase | 20 (74%) |
 Acute phase | 20 (74%) |
 Post-operative phase | 19 (70%) |
Number of patients who are listed for or have undergone TKR surgery seen during previous week (n = 27)b | |
 0 | 2 (7%) |
 1–2 | 4 (15%) |
 3–5 | 2 (7%) |
 6–10 | 9 (33%) |
  > 10 | 10 (37%) |